Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Reports Q4 EPS Beat, Revenue Growth, and Secures $5M Financing Post-Period

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$1.27
Mkt Cap
$2.436M
52W Low
$1.195
52W High
$56.28
Market data snapshot near publication time

summarizeSummary

Nuwellis, Inc. reported better-than-expected Q4 2025 financial results, including a 4% revenue increase and improved gross margins, alongside announcing a $5.0 million private placement and a strategic acquisition post-period.


check_boxKey Events

  • Q4 2025 Financial Performance Exceeds Expectations

    Nuwellis reported Q4 2025 revenue of $2.4 million, a 4% year-over-year increase, and a net loss of $1.50 per share, which was better than the expected $1.56 loss.

  • Significant Gross Margin Expansion

    The company achieved a gross margin of 68.2% in Q4 2025, a notable improvement from 58.4% in the prior-year quarter, driven by improved pricing and product mix.

  • Substantial Post-Period Capital Infusion

    Nuwellis strengthened its capital position by closing a $5.0 million private placement and warrant inducement transaction in January 2026, after the reporting period.

  • Strategic Acquisition and Leadership Appointment

    The company executed a definitive stock purchase agreement to acquire Rendiatech, expanding its cardiorenal portfolio, and appointed a new Chief Financial Officer in February 2026.


auto_awesomeAnalysis

This 8-K details Nuwellis's Q4 and full-year 2025 financial results, which show a positive turn in the fourth quarter with revenue growth and significant gross margin expansion. The reported net loss per share of $1.50 was better than analyst expectations, providing a positive signal. Crucially, the company announced a $5.0 million private placement completed in January 2026, which is a substantial capital infusion for a company of this size, significantly improving its liquidity and runway. Additionally, the strategic acquisition of Rendiatech and the appointment of a new CFO indicate a proactive approach to growth and operational strengthening. Investors should view the Q4 operational improvements and the post-period financing as key factors in the company's near-term stability and strategic direction.

At the time of this filing, NUWE was trading at $1.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $1.20 to $56.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NUWE - Latest Insights

NUWE
Apr 28, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
NUWE
Apr 24, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
NUWE
Apr 16, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
NUWE
Apr 06, 2026, 4:30 PM EDT
Filing Type: DEFA14A
Importance Score:
7
NUWE
Apr 02, 2026, 5:01 PM EDT
Filing Type: DEF 14A
Importance Score:
9
NUWE
Apr 01, 2026, 4:45 PM EDT
Filing Type: 8-K/A
Importance Score:
8
NUWE
Mar 31, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
NUWE
Mar 27, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
NUWE
Mar 27, 2026, 4:55 PM EDT
Filing Type: 8-K
Importance Score:
9
NUWE
Mar 17, 2026, 9:13 AM EDT
Filing Type: 8-K
Importance Score:
8